ATE465175T1 - Neuer proteinkomplex und anwendungen davon - Google Patents

Neuer proteinkomplex und anwendungen davon

Info

Publication number
ATE465175T1
ATE465175T1 AT05748510T AT05748510T ATE465175T1 AT E465175 T1 ATE465175 T1 AT E465175T1 AT 05748510 T AT05748510 T AT 05748510T AT 05748510 T AT05748510 T AT 05748510T AT E465175 T1 ATE465175 T1 AT E465175T1
Authority
AT
Austria
Prior art keywords
amino acid
acid sequence
same
seq
applications
Prior art date
Application number
AT05748510T
Other languages
English (en)
Inventor
Eiji Sunahara
Takafumi Ishii
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE465175T1 publication Critical patent/ATE465175T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT05748510T 2004-06-03 2005-06-02 Neuer proteinkomplex und anwendungen davon ATE465175T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004165407 2004-06-03
PCT/JP2005/010538 WO2005118631A1 (ja) 2004-06-03 2005-06-02 新規タンパク質複合体およびその用途

Publications (1)

Publication Number Publication Date
ATE465175T1 true ATE465175T1 (de) 2010-05-15

Family

ID=35462884

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05748510T ATE465175T1 (de) 2004-06-03 2005-06-02 Neuer proteinkomplex und anwendungen davon

Country Status (6)

Country Link
US (1) US20090087423A1 (de)
EP (1) EP1760087B1 (de)
JP (1) JPWO2005118631A1 (de)
AT (1) ATE465175T1 (de)
DE (1) DE602005020786D1 (de)
WO (1) WO2005118631A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5584385B2 (ja) * 2006-06-02 2014-09-03 東洋紡株式会社 ヒトパピローマウイルスの検出法及びタイピング方法
US11879000B2 (en) 2019-11-15 2024-01-23 National Guard Health Affairs Purification and identification of a protein complex containing b-cell lymphoma protein (BCL10)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000078961A1 (en) 1999-06-23 2000-12-28 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
NZ531664A (en) 1998-09-01 2005-07-29 Genentech Inc Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
AU2001280608A1 (en) 2000-07-18 2002-01-30 Curagen Corporation Human polynucleotides and polypeptides encoded thereby
AU2002220920A1 (en) 2000-12-08 2002-06-18 Oxford Biomedica (Uk) Limited Method for identification of genes involved in specific diseases
AU2002309583A1 (en) 2001-04-18 2002-11-05 Protein Desing Labs, Inc. Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
EP1577322A4 (de) 2002-12-26 2006-01-25 Takeda Pharmaceutical Neue proteine und ihre verwendung

Also Published As

Publication number Publication date
EP1760087A4 (de) 2007-07-11
EP1760087B1 (de) 2010-04-21
JPWO2005118631A1 (ja) 2008-05-29
DE602005020786D1 (de) 2010-06-02
EP1760087A1 (de) 2007-03-07
WO2005118631A1 (ja) 2005-12-15
US20090087423A1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
ATE361067T1 (de) Naphtoquinone derivate als inhibitoren von tau aggregation zur behandlung von alzheimer's und verbundenen neurodegenerativen erkrankungen
ATE384526T1 (de) N-(((((1,3-thiazol-2- yl)amino)carbonyl)phenyl)sulphonyl)phenylalanin derivate und verwandte verbindungen zur behandlung von diabetes
ATE353880T1 (de) Neue verwendung von pyrimidin- oder triazin-2- carbonsäurenitrilen zur behandlung von krankheiten, die mit cysteinproteaseaktivität assoziiert sind, und neue pyridimidin-2- carbonsäurenitrilderivate
BRPI0417101A (pt) uso de compostos de peptìdeo para tratamento de dor neuropática central
DE60128916D1 (de) Neues, physiologisch aktives peptid und dessen verwendung
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
WO2004078777A3 (en) Dipeptidyl-peptidase protected proteins
DE602004029812D1 (de) Fgf-5-bindende und geträgerte peptide
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
DE602005022113D1 (de) Phenyl)methanon-derivate als glycin-transporter 1 (glyt-1) hemmer zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
MX2009005622A (es) Dihidro-imidazoles sustituidos y su uso en el tratamiento de tumores.
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
WO2006087550A8 (en) Amyloid-binding peptides, analogues and uses thereof
CY1109975T1 (el) Παρα-αλκυλ-υποκατεστημενα αμιδια ν-(4-υδροξυ-3-μεθοξυ-βενζυλο) κιναμμωμικου οξεος και η χρησιμοποιηση τους για την παρασκευη φαρμακων
BRPI0415781A (pt) método para o tratamento de diabetes em um paciente e kit farmacêutico
WO2006019982A3 (en) Pin1-modulating compounds and methods of use thereof
ATE465175T1 (de) Neuer proteinkomplex und anwendungen davon
EP1666880A4 (de) Screening-verfahren
ATE399758T1 (de) Derivate von 1-phenylalkancarbonsäuren zur behandlung von neurodegenerativen krankheiten
ATE457727T1 (de) Kombination aus pyrimidylaminobenzamid- verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen
ATE397924T1 (de) Satraplatin zur behandlung von resistenten oder refrkatären tumoren
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
BR0308911A (pt) Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto
ATE485831T1 (de) Behandlung von neurodegeneration

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties